Serum hepatitis B virus RNA levels as a predictor of HBeAg seroconversion during treatment with peginterferon alfa-2a

BACKGROUND: Hepatitis B e antigen (HBeAg) seroconversion represents an endpoint of treatment of chronic hepatitis B virus (HBV) infections. METHODS: We have studied whether levels of serum hepatitis B virus ribonucleic acid (HBV RNA) during pegylated interferon alfa-2a treatment might be helpful for...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Wen, Zhu, Men Qi, Qi, Xun, Wang, Ting, Wen, Xiao, Chen, Pei Dong, Fan, Qing Qi, Zhang, Wen-Hong, Zhang, Ji Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505123/
https://www.ncbi.nlm.nih.gov/pubmed/31064399
http://dx.doi.org/10.1186/s12985-019-1152-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505123/
https://www.ncbi.nlm.nih.gov/pubmed/31064399
http://dx.doi.org/10.1186/s12985-019-1152-6

Ejemplares similares